Virpax Pharmaceuticals Inc

NASDAQ:VRPX   3:59:28 PM EDT
0.85
0.00 (0.00%)
7:23:09 PM EDT: $0.81 -0.04 (-4.47%)
Earnings Announcements

Virpax Pharmaceuticals Reports Third Quarter Results

Published: 11/09/2022 14:35 GMT
Virpax Pharmaceuticals Inc (VRPX) - Virpax Pharmaceuticals Reports 2022 Third Quarter Results.
Virpax Pharmaceuticals Inc - Qtrly Loss per Share $0.65.
Virpax Pharmaceuticals Inc - at September 30, 2022, Company Had Cash of Approximately $20.6 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.67

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.